Luminate Medical

Luminate Medical, founded in 2019, is a medical technology company that develops devices to prevent chemotherapy side effects and enable at-home cancer treatment.

The company's products include Lily, which addresses hair loss prevention during chemotherapy; Lotus, for enabling at-home infusions; and Lilac, to prevent peripheral neuropathy as a side effect. These technologies operate in the domains of medical devices, infusion therapy, and neuropathy prevention.

Luminate Medical has raised over 30 million euros in funding and has a geographic presence in Galway, Ireland, and the United States, working within the oncology and medical technology verticals.

The organization emphasizes patient-centric design, a collaborative approach with patients, providers, and partners, and a focus on humanizing cancer care.